DE69815143D1 - Behandlung von allergischen zuständen mit cystein- und serin-proteinase inhibitoren - Google Patents

Behandlung von allergischen zuständen mit cystein- und serin-proteinase inhibitoren

Info

Publication number
DE69815143D1
DE69815143D1 DE69815143T DE69815143T DE69815143D1 DE 69815143 D1 DE69815143 D1 DE 69815143D1 DE 69815143 T DE69815143 T DE 69815143T DE 69815143 T DE69815143 T DE 69815143T DE 69815143 D1 DE69815143 D1 DE 69815143D1
Authority
DE
Germany
Prior art keywords
treatment
cystein
proteinase inhibitors
serine proteinase
allergic conditions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69815143T
Other languages
English (en)
Other versions
DE69815143T2 (de
Inventor
David Ronald Garrod
Clive Robinson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Manchester Manchester Gb, University of
ST GEORG'S HOSPITAL MEDICAL SCHOOL LONDON GB
Original Assignee
ST GEORG S HOSPITAL MEDICAL SC
Victoria University of Manchester
University of Manchester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ST GEORG S HOSPITAL MEDICAL SC, Victoria University of Manchester, University of Manchester filed Critical ST GEORG S HOSPITAL MEDICAL SC
Application granted granted Critical
Publication of DE69815143D1 publication Critical patent/DE69815143D1/de
Publication of DE69815143T2 publication Critical patent/DE69815143T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DE69815143T 1997-12-11 1998-12-11 Behandlung von allergischen zuständen mit cystein- und serin-proteinase inhibitoren Expired - Lifetime DE69815143T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9726114 1997-12-11
GBGB9726114.3A GB9726114D0 (en) 1997-12-11 1997-12-11 Prevention and/or treatment of allergic conditions
PCT/GB1998/003721 WO1999029339A2 (en) 1997-12-11 1998-12-11 Prevention and/or treatment of allergic conditions

Publications (2)

Publication Number Publication Date
DE69815143D1 true DE69815143D1 (de) 2003-07-03
DE69815143T2 DE69815143T2 (de) 2004-04-01

Family

ID=10823401

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69815143T Expired - Lifetime DE69815143T2 (de) 1997-12-11 1998-12-11 Behandlung von allergischen zuständen mit cystein- und serin-proteinase inhibitoren

Country Status (13)

Country Link
US (1) US6440938B1 (de)
EP (1) EP1032415B1 (de)
JP (2) JP2001525374A (de)
AT (1) ATE241383T1 (de)
AU (1) AU747723C (de)
CA (1) CA2313653C (de)
DE (1) DE69815143T2 (de)
ES (1) ES2200394T3 (de)
GB (1) GB9726114D0 (de)
HR (1) HRP20000450A2 (de)
HU (1) HUP0100788A2 (de)
PT (1) PT1032415E (de)
WO (1) WO1999029339A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0125594D0 (en) * 2001-10-25 2001-12-19 Univ Sheffield Inhibitors for inactivating allergens
WO2016042131A1 (en) * 2014-09-18 2016-03-24 The Provost, Fellows, Foundation Scholars, & The Other Members Of Board, Of The College Of The Holy & Undiv. Trinity Of Queen Elizabeth Near Dublin Use of inhibitors of il-36 proteolytic processing for the treatment and/or reduction of inflammation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166134A (en) * 1986-12-24 1992-11-24 John Lezdey Treatment of allergic rhinitis
DE69633623T2 (de) * 1995-07-17 2005-12-01 Medivir Uk Ltd. Cystein-Protease-Inhibitoren für die Behandlung von allergischen Krankheiten verursacht duch IgE

Also Published As

Publication number Publication date
US6440938B1 (en) 2002-08-27
EP1032415A2 (de) 2000-09-06
AU747723C (en) 2003-10-02
DE69815143T2 (de) 2004-04-01
HRP20000450A2 (en) 2001-06-30
ES2200394T3 (es) 2004-03-01
HUP0100788A2 (hu) 2001-06-28
JP2001525374A (ja) 2001-12-11
WO1999029339A2 (en) 1999-06-17
AU1498599A (en) 1999-06-28
GB9726114D0 (en) 1998-02-11
ATE241383T1 (de) 2003-06-15
WO1999029339A3 (en) 1999-08-12
AU747723B2 (en) 2002-05-23
CA2313653C (en) 2011-02-01
PT1032415E (pt) 2003-09-30
JP2010155831A (ja) 2010-07-15
CA2313653A1 (en) 1999-06-17
EP1032415B1 (de) 2003-05-28

Similar Documents

Publication Publication Date Title
TR199801151T2 (xx) Trombin inhibit�r� �n ila�lar.
ATE310087T1 (de) Plasma-kallikrein inhibitoren vom kunitz-typ
IS6069A (is) N-cýanómetýlamíð sem próteasalatar
TR199901191T2 (xx) Benzamidoaldehitlerin sistein proteaz� inhibit�r� olarak kullan�m�.
NO20005888D0 (no) Benzimidale derivater som mudulatorer av IgE
ATE520411T1 (de) Behandlung und prävention von lungenerkrankungen
ATE377006T1 (de) Aus d-aminosäuren abgeleitete cystein- und serinproteasehemmer
NO20061736L (no) Krystallform av epotilon B
ATE193304T1 (de) Inhibitoren der menschlichen neutrophilenelastase
MEP90508A (en) New pharmaceutical composition
MX9800146A (es) Nuevos inhibidores de trombina, su preparacion y su uso.
ATE439853T1 (de) Zusammensetzung zur behandlung von ichthyosis unter verwendung von antitrypsin
NO983688L (no) Serin-protease-inhibitorer
ATE318606T1 (de) Zusammenstellungen zur prophylaxe und behandlung von allergien des typus i
HK1016495A1 (en) Phosphorous-containing cysteine and serine protease inhibitors
ATE277943T1 (de) Trypsininhibitoren
DE69814444D1 (de) Kombination von angiotensing-convertin-enzyme hemmern mit diuretikum zur behandlung von störungen der mikrozirkulation
YU49422B (sh) Upotreba inhibitora ugljenične anhidraze za proizvodnju medikamenata za tretiranje makularnog edema ili makularne degeneracije izazvane starošću
DE69626671D1 (de) Fusionsproteine bestehend aus gewebefaktor-kunitzdomäne als inhibitoren des faktors viia
DK0652900T3 (da) Thrombininhibitorer
ATE241383T1 (de) Behandlung von allergischen zuständen mit cystein-und serin-proteinase inhibitoren
ATE218877T1 (de) Bowman-birk-inhibitorzusammensetzungen zur behandlung von entzündungskrankheiten
ATE290878T1 (de) Inhibierung von invasiver remodulierung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: THE UNIVERSITY OF MANCHESTER, MANCHESTER, GB

Owner name: ST. GEORG'S HOSPITAL MEDICAL SCHOOL, LONDON, GB

8328 Change in the person/name/address of the agent

Representative=s name: PATENTANWAELTE ZELLENTIN & PARTNER GBR, 81667 MUENCHEN